Kingsview Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.19M | Sell |
15,711
-752
| -5% | -$105K | 0.03% | 491 |
|
|
2025
Q4 | $2.02M | Sell |
16,463
-50
| -0.3% | -$6.08K | 0.03% | 473 |
|
|
2025
Q3 | $1.83M | Sell |
16,513
-24,866
| -60% | -$2.83M | 0.03% | 469 |
|
|
2025
Q2 | $4.59M | Sell |
41,379
-1,872
| -4% | -$199K | 0.08% | 265 |
|
|
2025
Q1 | $4.85M | Buy |
43,251
+1,237
| +3% | +$128K | 0.09% | 223 |
|
|
2024
Q4 | $3.88M | Buy |
42,014
+22,091
| +111% | +$1.99M | 0.08% | 246 |
|
|
2024
Q3 | $1.67M | Buy |
19,923
+1,628
| +9% | +$124K | 0.04% | 416 |
|
|
2024
Q2 | $1.26M | Sell |
18,295
-27
| -0.1% | -$1.8K | 0.03% | 450 |
|
|
2024
Q1 | $1.34M | Sell |
18,322
-406
| -2% | -$31.2K | 0.03% | 429 |
|
|
2023
Q4 | $1.52M | Sell |
18,728
-1,841
| -9% | -$143K | 0.05% | 348 |
|
|
2023
Q3 | $1.54M | Sell |
20,569
-18,612
| -48% | -$1.43M | 0.06% | 339 |
|
|
2023
Q2 | $3.02M | Sell |
39,181
-7,481
| -16% | -$597K | 0.12% | 186 |
|
|
2023
Q1 | $3.87M | Buy |
46,662
+12,949
| +38% | +$1.07M | 0.16% | 134 |
|
|
2022
Q4 | $2.89M | Buy |
33,713
+11,587
| +52% | +$918K | 0.13% | 191 |
|
|
2022
Q3 | $1.36M | Buy |
22,126
+3,342
| +18% | +$211K | 0.06% | 274 |
|
|
2022
Q2 | $1.16M | Sell |
18,784
-4,173
| -18% | -$258K | 0.06% | 327 |
|
|
2022
Q1 | $1.36M | Buy |
22,957
+4,978
| +28% | +$318K | 0.06% | 313 |
|
|
2021
Q4 | $1.3M | Buy |
17,979
+1,046
| +6% | +$72K | 0.05% | 321 |
|
|
2021
Q3 | $1.18M | Buy |
16,933
+1,014
| +6% | +$71.2K | 0.06% | 325 |
|
|
2021
Q2 | $1.1M | Buy |
15,919
+2,137
| +16% | +$143K | 0.05% | 351 |
|
|
2021
Q1 | $916K | Buy |
13,782
+695
| +5% | +$44.8K | 0.05% | 352 |
|
|
2020
Q4 | $762K | Sell |
13,087
-3,468
| -21% | -$209K | 0.06% | 340 |
|
|
2020
Q3 | $1.05M | Buy |
16,555
+2,242
| +16% | +$155K | 0.09% | 215 |
|
|
2020
Q2 | $1.1M | Buy |
14,313
+1,819
| +15% | +$139K | 0.11% | 189 |
|
|
2020
Q1 | $934K | Buy |
12,494
+8,444
| +208% | +$583K | 0.13% | 188 |
|
|
2019
Q4 | $263K | Buy |
+4,050
| New | +$264K | 0.03% | 391 |
|
|
2018
Q4 | – | Sell |
-2,635
| Closed | -$203K | – | 401 |
|
|
2018
Q3 | $203K | Buy |
+2,635
| New | +$199K | 0.04% | 339 |
|
|
2018
Q2 | – | Sell |
-3,423
| Closed | -$258K | – | 394 |
|
|
2018
Q1 | $258K | Buy |
+3,423
| New | +$272K | 0.06% | 273 |
|
|
2017
Q3 | – | Sell |
-3,274
| Closed | -$232K | – | 383 |
|
|
2017
Q2 | $232K | Sell |
3,274
-1,681
| -34% | -$112K | 0.12% | 219 |
|
|
2017
Q1 | $337K | Buy |
+4,955
| New | +$348K | 0.2% | 156 |
|
Other funds holding GILD
VCM
VPM
Kingsview Wealth Management's GILD Position: Q1 2026 in Review
Kingsview Wealth Management reduced its Gilead Sciences (GILD) stake by 4.6% in Q1 2026, selling an estimated $105K and leaving 15,711 shares worth $2.19M. The position accounts for 0.03% of the portfolio, ranked #491.
Kingsview Wealth Management first reported a position in GILD in Q1 2017 and has held it in 30 quarters since. The position peaked at $4.85M in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Kingsview Wealth Management held 15,711 shares of Gilead Sciences worth $2.19M as of Q1 2026.
- Kingsview Wealth Management sold 752 Gilead Sciences shares in Q1 2026, an estimated $105K.
- Gilead Sciences made up 0.03% of Kingsview Wealth Management's portfolio in Q1 2026, its #491 holding.
- Kingsview Wealth Management first reported a position in Gilead Sciences in Q1 2017 and has held it in 30 quarters since.
- Kingsview Wealth Management's Gilead Sciences position peaked at $4.85M in Q1 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.